Dose of Hemodialysis and Survival: A Marginal Structural Model Analysis

Comparing Mortality of Peritoneal and Hemodialysis Patients in the First 2 Years of Dialysis Therapy: A Marginal Structural Model Analysis

(2013) L. R. Lukowsky et al.   Clinical Journal of the American Society of Nephrology

Angiotensin-Converting Enzyme Inhibitor, Angiotensin Receptor Blocker Use, and Mortality in Patients With Chronic Kidney Disease

(2013) Miklos Z. Molnar et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Dialysis Dose Scaled to Body Surface Area and Size-Adjusted, Sex-Specific Patient Mortality

(2012) S. P. B. Ramirez et al.   Clinical Journal of the American Society of Nephrology

Administered paricalcitol dose and survival in hemodialysis patients: A marginal structural model analysis

(2012) Jessica E Miller et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Association of Residual Urine Output With Mortality, Quality of Life, and Inflammation in Incident Hemodialysis Patients: The Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study

(2010) Tariq Shafi et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Similar Outcomes With Hemodialysis and Peritoneal Dialysis in Patients With End-Stage Renal Disease

(2010) Rajnish Mehrotra et al.   ARCHIVES OF INTERNAL MEDICINE

Comparing Mortality in Renal Patients on Hemodialysis versus Peritoneal Dialysis Using a Marginal Structural Model

(2010) Willem M van der Wal et al.  

Fluid Retention Is Associated With Cardiovascular Mortality in Patients Undergoing Long-Term Hemodialysis

(2009) Kamyar Kalantar-Zadeh et al.   CIRCULATION

Hemodialysis-Induced Cardiac Injury: Determinants and Associated Outcomes

(2009) J. O. Burton et al.   Clinical Journal of the American Society of Nephrology